Aarti Pharmalabs

Price chart

Previous close

₹929.70

Open

₹928.55

Day high

₹960.00

Day low

₹915.60

Listed on NSE since 30 January 2023.

Market value

₹8,430.50 Cr

P/E (trailing)

32.86

EPS (trailing)

₹28.29

Price to book

3.97

Dividend yield

0.43%

Debt to equity

0.37

Profit margin

10.4%

Beta

0.33

Volume today

3.48 L

Average volume

9.78 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Aarti Pharmalabs’s results filed with NSE, consolidated (the whole group). Net profit is the share of Aarti Pharmalabs’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Aarti Pharmalabs’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates, such as xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. It serves pharmaceutical, nutraceutical, and beverage industries. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

2,421

Company website · Profile: Yahoo Finance

No headlines name Aarti Pharmalabs in the last day or two.

• Dividend - Rs 2 Per Share

  Dividend · ex-date 15 September 2026

• Interim Dividend - Rs 1.50 Per Share

  Dividend · ex-date 16 February 2026

• Dividend - Rs 2.50 Per Share

  Dividend · ex-date 15 September 2025

• Interim Dividend - Rs 2.50 Per Share

  Dividend · ex-date 14 February 2025

• Dividend - Re 1 Per Share

  Dividend · ex-date 31 July 2024

• Interim Dividend - Rs 2 Per Share

  Dividend · ex-date 16 February 2024 · record date 19 February 2024

Source: NSE. Latest first.